News
Early detection of deteriorating by nursing staff improves COVID-19 patient recovery
A study finds that systematized nursing surveillance through the VIDA system, developed by the Catalan Institute of Health and IDIBELL, can detect and prevent complications, transfers to the ICU, and intra-hospital mortality.
Anna Sureda, new president of the European Society for Bone Marrow Transplantation
This appointment represents a recognition of her professional life dedicated to hematopoietic stem cell transplantation and cell therapies.
The group led by Dr. Alessandra Giorgetti receives a grant from the GESMD to study myelodysplastic syndrome
The research group led by Dr. Alessandra Giorgetti, leader of the research group “Biology of Hematopoietic Stem Cells and Leukemogenesis” of IDIBELL, and professor at the UB, has received a grant of € 15,000 from the GESMD (Spanish Group of Myelodysplastic Syndromes), a group of which Giorgetti is an active member.
Remodeling of the IDIBELL animal facilities
Work financed by the Territorial Specialization and Competitiveness Project (PECT) “L’Hospitalet, innovative ecosystem in health.”
The impact of COVID-19 on research, analysis by Dr Capellá one year after the outbreak of the pandemic
Since the beginning of the COVID-19 pandemic, the health and scientific communities have made a formidable effort to respond, within their capabilities, to an unprecedented, rapidly evolving global situation of enormous complexity, and with a high harmful potential.
Elevated mortality in haematological patients due to COVID-19
IDIBELL and ICO researchers analise direct and indirect effects of the pandemic in haematological patients
The Clinical Research and Clinical Trials Unit renews its participation in the ISCIII Clinical Research Support Platform
The aid granted in the last competitive call for Clinical Research Support Platforms of the Carlos III Health Institute (ISCIII) almost triples that granted in the 2017 call, becoming one of the five best funded units of the 34 that make up the new ISCIII Platform throughout Spain.
The benefits of the Mediterranean diet pass on to the families of patients who follow it
A study led by IMIM-Hospital del Mar shows that, despite not participating in the programme, these people had lost an average of almost four kilos, two years after their family member started the programme
A step forward in personalized medicine against malignant pleural cancer
Researchers from IDIBELL and ICO establish a new classification of malignant mesothelioma that permits the prediction of the patient’s prognosis and determine those who could benefit from immunotherapy.